ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Rory Collins , Richard Peto , Marcus Flather , Sarah Parish , Peter Sleight , M Conway , A Pipilis , Colin Baigent , D Barnett , J P Boissel , Andrzej Budaj , John A. Cairns , L Ceremuzynski , Alexander T. Cohen , G Debacker , Rafael Diaz , F Dienstl , P Dove , MariaGrazia Franzosi , Genoni M , D Halon , J Heikkila , Charles H. Hennekens , J Horgan , D Hunt , R Kala , N Karatzas , Anthony C Keech , Matyas Keltai , J Kjekshus , M Kornitzer , R Koster , P Landless , P Lechleitner , Alain Leizorovicz , B Lewis , L Lundkvist , Stephen MacMahon , Aldo P. Maggioni , R Malacrida , T Meyer , Tiziano Moccetti , D Ocallaghan , Ernesto Paolasso , Leopoldo S. Piegas , A Reikvam , Paul M. Ridker , T Ryan , R Schroder , R Seabragomes , J Sousa , G Tognoni , Alexander G.G. Turpie , Valentin , J Varigos , H White , L Wilhelmsen , K Woods , Salim Yusuf , A Piombo , L Guzman , D Montenegro , G Irusta , R Schneider , C Cuneo , B Chamorro , G Espinosa , M Moreno , M Rios , Richard Doll , Keith A.A. Fox , D Julian , P Meier , E Sandoya , J Perez The Lancet（1995）
AI 理解论文
溯源树
样例
